Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Merck Down on Arthritis Study Merck (MRK:NYSE - news - research) shares fell early Thursday after a study sponsored by the Food and Drug Administration concluded that its Vioxx arthritis drug put users at a greater risk to heart attacks than Pfizer #39;s (PFE:NYSE - news - research 
